Regulatory Update | CDSCO / DCC | July 2026 The Drugs Consultative Committee (DCC), at its 69th meeting, took up a proposal aimed at tightening control over one of the least regulated links in the pharmaceutical supply chain: the manufacturers…
Recent Post
- CDSCO Directs Ibuprofen Manufacturers to Add ‘Fixed Drug Eruption’ to PILs
- No Registration Certificate, No Entry for Imported Cosmetics
- CDSCO Clarifies Jurisdiction for Compounding of Offences Applications
- CDSCO Notifies Final Guidance Document on Medical Device Software (MDSW)
- When a “+” Sign Isn’t Just a Plus
